Halozyme Therapeutics (HALO) Stock Chart & Stock Price History → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free HALO Stock Alerts $43.08 -0.74 (-1.69%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Halozyme Therapeutics Stock Price Performance5 Day Performance-1.69%1 Month Performance+11.12%3 Month Performance+8.21%6 Month Performance+11.90%Year-To-Date Performance+16.56%1 Year Performance+29.76% Receive HALO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyObama’s Forever Term [exposed]Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here HALO Stock Chart for Wednesday, May, 29, 2024 HALO Chart by TradingView Halozyme Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$43.82$43.08-1.69%$43.97$42.691.03 million shs$5.48 billion05/27/2024$43.82$43.82$44.02$42.96898,700 shs$5.58 billion05/24/2024$43.92$43.82-0.23%$44.02$42.96898,705 shs$5.58 billion05/23/2024$45.48$43.92-3.43%$45.48$43.751.17 million shs$5.59 billion05/22/2024$45.54$45.48-0.13%$45.88$45.08843,307 shs$5.79 billion05/21/2024$44.97$45.54+1.27%$45.57$44.72914,946 shs$5.80 billion Get the Latest News and Ratings for HALO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$44.71$44.97+0.58%$45.07$44.30656,825 shs$5.72 billion05/17/2024$45.39$44.71-1.50%$45.76$44.351.10 million shs$5.69 billion05/16/2024$45.82$45.39-0.94%$46.16$45.221.04 million shs$5.78 billion05/15/2024$43.82$45.82+4.56%$46.05$44.011.26 million shs$5.83 billion05/14/2024$43.61$43.82+0.48%$45.18$43.551.09 million shs$5.58 billion05/13/2024$43.15$43.61+1.07%$44.00$43.36908,619 shs$5.49 billion05/10/2024$43.84$43.15-1.57%$44.21$43.121.03 million shs$5.48 billion05/09/2024$42.01$43.84+4.36%$43.92$41.301.44 million shs$5.57 billion05/08/2024$41.21$42.01+1.94%$44.79$41.432.12 million shs$5.34 billion05/07/2024$40.86$41.21+0.86%$41.65$40.871.28 million shs$5.24 billion05/06/2024$39.91$40.86+2.38%$40.97$40.23981,063 shs$5.19 billion05/03/2024$39.82$39.91+0.23%$40.74$39.79902,786 shs$5.07 billion05/02/2024$39.30$39.82+1.32%$40.41$38.88832,175 shs$5.06 billion05/01/2024$38.10$39.30+3.15%$40.00$38.291.03 million shs$4.99 billion04/30/2024$38.77$38.10-1.73%$39.03$37.97922,290 shs$4.84 billion04/29/2024$38.57$38.77+0.52%$39.38$38.56728,580 shs$4.93 billion04/26/2024$38.46$38.57+0.29%$39.02$38.46547,082 shs$4.90 billion04/25/2024$39.12$38.46-1.69%$38.75$38.23693,348 shs$4.89 billion04/24/2024$38.97$39.12+0.38%$39.69$38.89620,516 shs$4.97 billion04/23/2024$38.71$38.97+0.67%$39.42$38.75557,947 shs$4.95 billion04/22/2024$38.64$38.71+0.18%$39.04$38.28525,232 shs$4.92 billion04/19/2024$37.81$38.64+2.20%$38.69$37.731.26 million shs$4.91 billion04/18/2024$38.02$37.81-0.55%$38.41$37.73792,530 shs$4.80 billion04/17/2024$38.38$38.02-0.94%$38.78$37.98733,857 shs$4.83 billion04/16/2024$38.72$38.38-0.88%$38.81$38.10642,294 shs$4.88 billion04/15/2024$38.61$38.72+0.28%$39.27$38.48843,653 shs$4.92 billion04/12/2024$39.32$38.61-1.81%$39.28$38.53780,317 shs$4.91 billion04/11/2024$39.28$39.32+0.10%$39.78$39.16733,619 shs$5.00 billion04/10/2024$40.13$39.28-2.12%$39.83$38.901.88 million shs$4.99 billion04/09/2024$39.91$40.13+0.55%$40.71$39.52719,098 shs$5.10 billion04/08/2024$41.07$39.91-2.82%$41.36$39.851.16 million shs$5.07 billion04/05/2024$39.73$41.07+3.37%$41.50$39.801.33 million shs$5.22 billion04/04/2024$40.23$39.73-1.24%$40.59$39.441.04 million shs$5.05 billion04/03/2024$40.43$40.23-0.49%$40.67$39.99679,659 shs$5.11 billionYou won't believe what Citigroup just did to it's depositors (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW04/02/2024$41.32$40.43-2.15%$40.81$39.70943,225 shs$5.14 billion04/01/2024$40.68$41.32+1.57%$41.60$40.38801,003 shs$5.25 billion03/29/2024$40.68$40.68$40.99$40.44707,395 shs$5.17 billion03/28/2024$40.73$40.68-0.12%$40.96$40.45707,132 shs$5.17 billion03/27/2024$40.08$40.73+1.62%$40.94$40.33601,140 shs$5.17 billion03/26/2024$40.42$40.08-0.84%$40.57$39.94625,814 shs$5.09 billion03/25/2024$40.08$40.42+0.85%$40.61$39.90672,983 shs$5.14 billion03/22/2024$40.22$40.08-0.35%$41.03$40.04794,808 shs$5.09 billion03/21/2024$40.38$40.22-0.40%$42.30$40.12928,092 shs$5.11 billion03/20/2024$40.81$40.38-1.05%$40.58$39.69837,234 shs$5.13 billion03/19/2024$40.37$40.81+1.09%$41.33$40.46847,975 shs$5.18 billion03/18/2024$40.86$40.37-1.20%$40.96$40.321.05 million shs$5.13 billion03/15/2024$40.79$40.86+0.17%$41.43$40.561.83 million shs$5.19 billion03/14/2024$41.35$40.79-1.35%$41.31$39.941.50 million shs$5.18 billion03/13/2024$41.95$41.35-1.43%$42.64$41.151.18 million shs$5.25 billion03/12/2024$41.20$41.95+1.82%$42.11$41.28964,210 shs$5.33 billion03/11/2024$41.73$41.20-1.27%$42.25$40.96864,505 shs$5.23 billion03/08/2024$41.71$41.73+0.05%$42.52$41.68852,160 shs$5.30 billion03/07/2024$41.69$41.71+0.05%$42.40$41.65948,912 shs$5.29 billion03/06/2024$41.41$41.69+0.68%$42.08$41.241.03 million shs$5.29 billion03/05/2024$40.93$41.41+1.17%$41.56$40.46929,145 shs$5.25 billion03/04/2024$41.11$40.93-0.44%$41.54$40.64694,332 shs$5.19 billion03/01/2024$39.81$41.11+3.27%$41.86$40.001.27 million shs$5.21 billion02/29/2024$39.69$39.81+0.30%$40.41$39.391.22 million shs$5.05 billion02/28/2024$39.84$39.69-0.38%$39.90$39.23905,402 shs$5.03 billion Related Companies: IOVA Stock Chart TWST Stock Chart RLAY Stock Chart ADPT Stock Chart ALLO Stock Chart FATE Stock Chart KOD Stock Chart ALNY Stock Chart NBIX Stock Chart BMRN Stock Chart Receive HALO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HALO) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsBiden replacement revealed?Paradigm PressTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.